The German stock market remained largely stagnant throughout most of the session but saw a
89bio, Inc., based in San Francisco, California, is a clinical-stage biopharmaceutical firm focused on developing
The German stock market remained largely stagnant throughout most of the session but saw a
89bio, Inc., based in San Francisco, California, is a clinical-stage biopharmaceutical firm focused on developing